4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-054623
Options or other derivatives
- Chief Medical Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2019-10-30 | Grant or award · Restricted stock units | +175,000 | 175,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…